China to mass produce Ebola vaccine
October 14, 2015  11:19
image
A private Chinese biotechnology company is planning to mass produce a vaccine to contain Ebola virus. Tianjin CanSino Biotechnology Inc has started construction of an industry base to produce the vaccine, developed by a team of biotech experts with the Chinese Academy of Military Medical Sciences, in the Tianjin Economic and Technological Development Area, the company said. Investment into the base totals 2 billion yuan (about USD 317 million) and construction will be complete in September, 2018.
« Back to LIVE

TOP STORIES